Spots Global Cancer Trial Database for iga monoclonal gammopathy
Every month we try and update this database with for iga monoclonal gammopathy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Rifaximin in Patients With Monoclonal Gammopathy | NCT03820817 | IgA Monoclonal ... IgG Monoclonal ... IgM Monoclonal ... Light Chain Dep... Monoclonal Gamm... Smoldering Wald... Waldenstrom Mac... Gammopathy, Mon... Gammopathy Igg | Rifaximin | 18 Years - | Emory University | |
Rifaximin in Patients With Monoclonal Gammopathy | NCT03820817 | IgA Monoclonal ... IgG Monoclonal ... IgM Monoclonal ... Light Chain Dep... Monoclonal Gamm... Smoldering Wald... Waldenstrom Mac... Gammopathy, Mon... Gammopathy Igg | Rifaximin | 18 Years - | Emory University |